{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:10:37Z","timestamp":1657757437217},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T00:00:00Z","timestamp":1479340800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s40261-016-0482-z","type":"journal-article","created":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T10:49:55Z","timestamp":1479379795000},"page":"273-283","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Quantifying the Exposure of Tapentadol Extended Release in Japanese Patients with Cancer Pain and Bridging Tapentadol Pharmacokinetics Across Populations Using a Modeling Approach"],"prefix":"10.1007","volume":"37","author":[{"given":"Liping","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayori","family":"Nobe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Zannikos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mila","family":"Etropolski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Partha","family":"Nandy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,17]]},"reference":[{"key":"482_CR1","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1526-5900(03)00556-X","volume":"4","author":"E McNicol","year":"2003","unstructured":"McNicol E, Horowicz-Mehler N, Fisk RA, Bennett K, Gialeli-Goudas M, Chew PW, et al. Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. J Pain Off J Am Pain Soc. 2003;4:231\u201356.","journal-title":"J Pain Off J Am Pain Soc."},{"key":"482_CR2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2147\/JPR.S14842","volume":"4","author":"N Vadivelu","year":"2011","unstructured":"Vadivelu N, Timchenko A, Hyang Y, Sinatra R. Tapentadol extended-release for treatment of chronic pain: a review. J Pain Res. 2011;4:211\u201318.","journal-title":"J Pain Res"},{"key":"482_CR3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.36076\/ppj.2013\/16\/27","volume":"16","author":"M Afilalo","year":"2013","unstructured":"Afilalo M, Morlion B. Efficacy of tapentadol ER for managing moderate to severe chronic pain. Pain Physician. 2013;16:27\u201340.","journal-title":"Pain Physician."},{"key":"482_CR4","unstructured":"Nucynta. Nucynta\u00ae ER (tapentadol) extended release oral tablets C-II [prescribing information]. Raritan: Janssen Pharmaceuticals, Inc; 2011."},{"key":"482_CR5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF03190478","volume":"32","author":"R Terlinden","year":"2007","unstructured":"Terlinden R, Ossig J, Fliegert F, Lange C, G\u00f6hler K. Absorption, metabolism, and excretion of 14C-labeled tapentadol HCl in healthy male subjects. Eur J Drug Metab Pharmacokinet. 2007;32:163\u20139.","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"482_CR6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1358\/mf.2010.32.1.1434165","volume":"32","author":"R Terlinden","year":"2010","unstructured":"Terlinden R, Kogel BY, Englberger W, Tzschentke TM. In vitro and in vivo characterization of tapentadol metabolites. Methods Find Exp Clin Pharmacol. 2010;32:31.","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"482_CR7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.5055\/jom.2013.0171","volume":"9","author":"PN Zannikos","year":"2013","unstructured":"Zannikos PN, Smit JW, Stahlberg H-J, Wenge B, Hillewaert VM, Etropolski MS. Pharmacokinetic evaluation of tapentadol extended-release tablets in healthy subjects. J Opioid Manag. 2013;9:291\u2013300.","journal-title":"J Opioid Manag"},{"key":"482_CR8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s40261-015-0371-x","volume":"36","author":"DR Huntjens","year":"2016","unstructured":"Huntjens DR, Liefaard LC, Nandy P, Drenth H-J, Vermeulen A. Population pharmacokinetic modeling of tapentadol extended release (ER) in healthy subjects and patients with moderate or severe chronic pain. Clin Drug Invest. 2016;36:213\u201323.","journal-title":"Clin Drug Invest."},{"key":"482_CR9","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s12325-010-0036-3","volume":"27","author":"B Lange","year":"2010","unstructured":"Lange B, Kuperwasser B, Okamoto A, Steup A, H\u00e4ufel T, Ashworth J, et al. Efficacy and safety of tapentadol prolonged release for chronic osteoarthritis pain and low back pain. Adv Ther. 2010;27:381\u201399.","journal-title":"Adv Ther."},{"key":"482_CR10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1185\/03007995.2010.537589","volume":"27","author":"S Schwartz","year":"2011","unstructured":"Schwartz S, Etropolski M, Shapiro DY, Okamoto A, Lange R, Haeussler J, et al. Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial. Curr Med Res Opin. 2011;27:151\u201362.","journal-title":"Curr Med Res Opin"},{"key":"482_CR11","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1185\/03007995.2013.831816","volume":"29","author":"K Imanaka","year":"2013","unstructured":"Imanaka K, Tominaga Y, Etropolski M, van Hove I, Ohsaka M, Wanibe M, et al. Efficacy and safety of oral tapentadol extended release in Japanese and Korean patients with moderate to severe, chronic malignant tumor-related pain. Curr Med Res Opin. 2013;29:1399\u2013409.","journal-title":"Curr Med Res Opin"},{"key":"482_CR12","unstructured":"A Safety and Efficacy Study of Oral Tapentadol Extended-Release in Japanese Participants; ClinicalTrials.gov Identifier: NCT01309386 [Internet]. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01309386 ."},{"key":"482_CR13","unstructured":"Beal S, Sheiner L, Boeckmann A, Bauer RJ. NONMEM user\u2019s guides. Ellicott: Icon Development Solutions; 1989\u20132009."},{"key":"482_CR14","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1345\/aph.1E260","volume":"38","author":"EI Ette","year":"2004","unstructured":"Ette EI. Population pharmacokinetics III: design, analysis, and application of population pharmacokinetic studies. Ann Pharmacother. 2004;38:2136\u201344.","journal-title":"Ann Pharmacother"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-016-0482-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-016-0482-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-016-0482-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T23:49:47Z","timestamp":1657756187000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-016-0482-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,17]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["482"],"URL":"https:\/\/doi.org\/10.1007\/s40261-016-0482-z","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,17]]}}}